|
52
|
Godefroy O, Yaïche H, Taillia H, Bompaire F, Nédélec-Ciceri C, Bonnin C, Varvat J, Vincent-Grangette F, Diouf M, Mas JL, Canaple S, Lamy C, Arnoux A, Leclercq C, Tasseel-Ponche S, Roussel M, Barbay M. Who should undergo a comprehensive cognitive assessment after a stroke? A cognitive risk score. Neurology 2018; 91:e1979-e1987. [PMID: 30333160 DOI: 10.1212/wnl.0000000000006544] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/19/2017] [Accepted: 08/13/2018] [Indexed: 11/15/2022] Open
Abstract
OBJECTIVE To validate the ability of a specifically developed cognitive risk score to identify patients at risk of poststroke neurocognitive disorders (NCDs) who are eligible for a comprehensive cognitive assessment. METHODS After assessing 404 patients (infarct 91.3%) in the Groupe de Réflexion pour l'Evaluation Cognitive VASCulaire (GRECogVASC) cross-sectional study with the National Institute of Neurological Disorders and Stroke-Canadian Stroke Network battery 6 months after stroke, we used multivariable logistic regression and bootstrap analyses to determine factors associated with NCDs. Independent, internally validated factors were included in a cognitive risk score. RESULTS Cognitive impairment was present in 170 of the 320 patients with a Rankin Scale score ≥1. The backward logistic regression selected 4 factors (≥73% of the permutations): NIH Stroke Scale score on admission ≥7 (odds ratio [OR] 2.73, 95% confidence interval [CI] 1.29-4.3, p = 0.005), multiple strokes (OR 3.78, 95% CI 1.6-8, p = 0.002), adjusted Mini-Mental State Examination (MMSEadj) score ≤27 (OR 6.69, 95% CI 3.9-11.6, p = 0.0001), and Fazekas score ≥2 (OR 2.34, 95% CI 1.3-4.2, p = 0.004). The cognitive risk score computed with these 4 factors provided good calibration, discrimination (overoptimism-corrected C = 0.793), and goodness of fit (Hosmer-Lemeshow test p = 0.99). A combination of Rankin Scale score ≥1, cognitive risk score ≥1, and MMSEadj score ≥21 selected 230 (56.9%) of the 404 patients for a comprehensive assessment. This procedure yielded good sensitivity (96.5%) and moderate specificity (43%; positive predictive value 0.66, negative predictive value 0.91) and was more accurate (p ≤ 0.03 for all) than the sole use of screening tests (MMSE or Montréal Cognitive Assessment). CONCLUSION The GRECogVASC cognitive risk score comprises 4 easily documented factors; this procedure helps to identify patients at risk of poststroke NCDs who must therefore undergo a comprehensive assessment. CLINICALTRIALSGOV IDENTIFIER NCT01339195.
Collapse
Affiliation(s)
- Olivier Godefroy
- From the Department of Neurology (O.G., H.Y., S.C., C.L., A.A., C.L., M.R., M.B.), Amiens University Hospital; Laboratory of Functional Neurosciences (O.G., H.Y., J.S.C., C.L., A.A., C.L., M.R., M.B.) (EA 4559), Department of Biostatistics (M.D.), and Department of Rehabilitation (S.T.-P.), Jules Verne University of Picardie, Amiens; Department of Neurology (H.T., F.B.), Val-de-Grâce Hospital, Paris; Department of Neurology (C.N.-C. C.B.), La Rochelle Hospital; Department of Neurology (J.V., F.V.-G.), Saint-Étienne University Hospital; and Department of Neurology (J.-L.M.), Saint Anne Hospital, Paris, France.
| | - Hugo Yaïche
- From the Department of Neurology (O.G., H.Y., S.C., C.L., A.A., C.L., M.R., M.B.), Amiens University Hospital; Laboratory of Functional Neurosciences (O.G., H.Y., J.S.C., C.L., A.A., C.L., M.R., M.B.) (EA 4559), Department of Biostatistics (M.D.), and Department of Rehabilitation (S.T.-P.), Jules Verne University of Picardie, Amiens; Department of Neurology (H.T., F.B.), Val-de-Grâce Hospital, Paris; Department of Neurology (C.N.-C. C.B.), La Rochelle Hospital; Department of Neurology (J.V., F.V.-G.), Saint-Étienne University Hospital; and Department of Neurology (J.-L.M.), Saint Anne Hospital, Paris, France
| | - Hervé Taillia
- From the Department of Neurology (O.G., H.Y., S.C., C.L., A.A., C.L., M.R., M.B.), Amiens University Hospital; Laboratory of Functional Neurosciences (O.G., H.Y., J.S.C., C.L., A.A., C.L., M.R., M.B.) (EA 4559), Department of Biostatistics (M.D.), and Department of Rehabilitation (S.T.-P.), Jules Verne University of Picardie, Amiens; Department of Neurology (H.T., F.B.), Val-de-Grâce Hospital, Paris; Department of Neurology (C.N.-C. C.B.), La Rochelle Hospital; Department of Neurology (J.V., F.V.-G.), Saint-Étienne University Hospital; and Department of Neurology (J.-L.M.), Saint Anne Hospital, Paris, France
| | - Flavie Bompaire
- From the Department of Neurology (O.G., H.Y., S.C., C.L., A.A., C.L., M.R., M.B.), Amiens University Hospital; Laboratory of Functional Neurosciences (O.G., H.Y., J.S.C., C.L., A.A., C.L., M.R., M.B.) (EA 4559), Department of Biostatistics (M.D.), and Department of Rehabilitation (S.T.-P.), Jules Verne University of Picardie, Amiens; Department of Neurology (H.T., F.B.), Val-de-Grâce Hospital, Paris; Department of Neurology (C.N.-C. C.B.), La Rochelle Hospital; Department of Neurology (J.V., F.V.-G.), Saint-Étienne University Hospital; and Department of Neurology (J.-L.M.), Saint Anne Hospital, Paris, France
| | - Claudine Nédélec-Ciceri
- From the Department of Neurology (O.G., H.Y., S.C., C.L., A.A., C.L., M.R., M.B.), Amiens University Hospital; Laboratory of Functional Neurosciences (O.G., H.Y., J.S.C., C.L., A.A., C.L., M.R., M.B.) (EA 4559), Department of Biostatistics (M.D.), and Department of Rehabilitation (S.T.-P.), Jules Verne University of Picardie, Amiens; Department of Neurology (H.T., F.B.), Val-de-Grâce Hospital, Paris; Department of Neurology (C.N.-C. C.B.), La Rochelle Hospital; Department of Neurology (J.V., F.V.-G.), Saint-Étienne University Hospital; and Department of Neurology (J.-L.M.), Saint Anne Hospital, Paris, France
| | - Camille Bonnin
- From the Department of Neurology (O.G., H.Y., S.C., C.L., A.A., C.L., M.R., M.B.), Amiens University Hospital; Laboratory of Functional Neurosciences (O.G., H.Y., J.S.C., C.L., A.A., C.L., M.R., M.B.) (EA 4559), Department of Biostatistics (M.D.), and Department of Rehabilitation (S.T.-P.), Jules Verne University of Picardie, Amiens; Department of Neurology (H.T., F.B.), Val-de-Grâce Hospital, Paris; Department of Neurology (C.N.-C. C.B.), La Rochelle Hospital; Department of Neurology (J.V., F.V.-G.), Saint-Étienne University Hospital; and Department of Neurology (J.-L.M.), Saint Anne Hospital, Paris, France
| | - Jérôme Varvat
- From the Department of Neurology (O.G., H.Y., S.C., C.L., A.A., C.L., M.R., M.B.), Amiens University Hospital; Laboratory of Functional Neurosciences (O.G., H.Y., J.S.C., C.L., A.A., C.L., M.R., M.B.) (EA 4559), Department of Biostatistics (M.D.), and Department of Rehabilitation (S.T.-P.), Jules Verne University of Picardie, Amiens; Department of Neurology (H.T., F.B.), Val-de-Grâce Hospital, Paris; Department of Neurology (C.N.-C. C.B.), La Rochelle Hospital; Department of Neurology (J.V., F.V.-G.), Saint-Étienne University Hospital; and Department of Neurology (J.-L.M.), Saint Anne Hospital, Paris, France
| | - Françoise Vincent-Grangette
- From the Department of Neurology (O.G., H.Y., S.C., C.L., A.A., C.L., M.R., M.B.), Amiens University Hospital; Laboratory of Functional Neurosciences (O.G., H.Y., J.S.C., C.L., A.A., C.L., M.R., M.B.) (EA 4559), Department of Biostatistics (M.D.), and Department of Rehabilitation (S.T.-P.), Jules Verne University of Picardie, Amiens; Department of Neurology (H.T., F.B.), Val-de-Grâce Hospital, Paris; Department of Neurology (C.N.-C. C.B.), La Rochelle Hospital; Department of Neurology (J.V., F.V.-G.), Saint-Étienne University Hospital; and Department of Neurology (J.-L.M.), Saint Anne Hospital, Paris, France
| | - Momar Diouf
- From the Department of Neurology (O.G., H.Y., S.C., C.L., A.A., C.L., M.R., M.B.), Amiens University Hospital; Laboratory of Functional Neurosciences (O.G., H.Y., J.S.C., C.L., A.A., C.L., M.R., M.B.) (EA 4559), Department of Biostatistics (M.D.), and Department of Rehabilitation (S.T.-P.), Jules Verne University of Picardie, Amiens; Department of Neurology (H.T., F.B.), Val-de-Grâce Hospital, Paris; Department of Neurology (C.N.-C. C.B.), La Rochelle Hospital; Department of Neurology (J.V., F.V.-G.), Saint-Étienne University Hospital; and Department of Neurology (J.-L.M.), Saint Anne Hospital, Paris, France
| | - Jean-Louis Mas
- From the Department of Neurology (O.G., H.Y., S.C., C.L., A.A., C.L., M.R., M.B.), Amiens University Hospital; Laboratory of Functional Neurosciences (O.G., H.Y., J.S.C., C.L., A.A., C.L., M.R., M.B.) (EA 4559), Department of Biostatistics (M.D.), and Department of Rehabilitation (S.T.-P.), Jules Verne University of Picardie, Amiens; Department of Neurology (H.T., F.B.), Val-de-Grâce Hospital, Paris; Department of Neurology (C.N.-C. C.B.), La Rochelle Hospital; Department of Neurology (J.V., F.V.-G.), Saint-Étienne University Hospital; and Department of Neurology (J.-L.M.), Saint Anne Hospital, Paris, France
| | - Sandrine Canaple
- From the Department of Neurology (O.G., H.Y., S.C., C.L., A.A., C.L., M.R., M.B.), Amiens University Hospital; Laboratory of Functional Neurosciences (O.G., H.Y., J.S.C., C.L., A.A., C.L., M.R., M.B.) (EA 4559), Department of Biostatistics (M.D.), and Department of Rehabilitation (S.T.-P.), Jules Verne University of Picardie, Amiens; Department of Neurology (H.T., F.B.), Val-de-Grâce Hospital, Paris; Department of Neurology (C.N.-C. C.B.), La Rochelle Hospital; Department of Neurology (J.V., F.V.-G.), Saint-Étienne University Hospital; and Department of Neurology (J.-L.M.), Saint Anne Hospital, Paris, France
| | - Chantal Lamy
- From the Department of Neurology (O.G., H.Y., S.C., C.L., A.A., C.L., M.R., M.B.), Amiens University Hospital; Laboratory of Functional Neurosciences (O.G., H.Y., J.S.C., C.L., A.A., C.L., M.R., M.B.) (EA 4559), Department of Biostatistics (M.D.), and Department of Rehabilitation (S.T.-P.), Jules Verne University of Picardie, Amiens; Department of Neurology (H.T., F.B.), Val-de-Grâce Hospital, Paris; Department of Neurology (C.N.-C. C.B.), La Rochelle Hospital; Department of Neurology (J.V., F.V.-G.), Saint-Étienne University Hospital; and Department of Neurology (J.-L.M.), Saint Anne Hospital, Paris, France
| | - Audrey Arnoux
- From the Department of Neurology (O.G., H.Y., S.C., C.L., A.A., C.L., M.R., M.B.), Amiens University Hospital; Laboratory of Functional Neurosciences (O.G., H.Y., J.S.C., C.L., A.A., C.L., M.R., M.B.) (EA 4559), Department of Biostatistics (M.D.), and Department of Rehabilitation (S.T.-P.), Jules Verne University of Picardie, Amiens; Department of Neurology (H.T., F.B.), Val-de-Grâce Hospital, Paris; Department of Neurology (C.N.-C. C.B.), La Rochelle Hospital; Department of Neurology (J.V., F.V.-G.), Saint-Étienne University Hospital; and Department of Neurology (J.-L.M.), Saint Anne Hospital, Paris, France
| | - Claire Leclercq
- From the Department of Neurology (O.G., H.Y., S.C., C.L., A.A., C.L., M.R., M.B.), Amiens University Hospital; Laboratory of Functional Neurosciences (O.G., H.Y., J.S.C., C.L., A.A., C.L., M.R., M.B.) (EA 4559), Department of Biostatistics (M.D.), and Department of Rehabilitation (S.T.-P.), Jules Verne University of Picardie, Amiens; Department of Neurology (H.T., F.B.), Val-de-Grâce Hospital, Paris; Department of Neurology (C.N.-C. C.B.), La Rochelle Hospital; Department of Neurology (J.V., F.V.-G.), Saint-Étienne University Hospital; and Department of Neurology (J.-L.M.), Saint Anne Hospital, Paris, France
| | - Sophie Tasseel-Ponche
- From the Department of Neurology (O.G., H.Y., S.C., C.L., A.A., C.L., M.R., M.B.), Amiens University Hospital; Laboratory of Functional Neurosciences (O.G., H.Y., J.S.C., C.L., A.A., C.L., M.R., M.B.) (EA 4559), Department of Biostatistics (M.D.), and Department of Rehabilitation (S.T.-P.), Jules Verne University of Picardie, Amiens; Department of Neurology (H.T., F.B.), Val-de-Grâce Hospital, Paris; Department of Neurology (C.N.-C. C.B.), La Rochelle Hospital; Department of Neurology (J.V., F.V.-G.), Saint-Étienne University Hospital; and Department of Neurology (J.-L.M.), Saint Anne Hospital, Paris, France
| | - Martine Roussel
- From the Department of Neurology (O.G., H.Y., S.C., C.L., A.A., C.L., M.R., M.B.), Amiens University Hospital; Laboratory of Functional Neurosciences (O.G., H.Y., J.S.C., C.L., A.A., C.L., M.R., M.B.) (EA 4559), Department of Biostatistics (M.D.), and Department of Rehabilitation (S.T.-P.), Jules Verne University of Picardie, Amiens; Department of Neurology (H.T., F.B.), Val-de-Grâce Hospital, Paris; Department of Neurology (C.N.-C. C.B.), La Rochelle Hospital; Department of Neurology (J.V., F.V.-G.), Saint-Étienne University Hospital; and Department of Neurology (J.-L.M.), Saint Anne Hospital, Paris, France
| | - Mélanie Barbay
- From the Department of Neurology (O.G., H.Y., S.C., C.L., A.A., C.L., M.R., M.B.), Amiens University Hospital; Laboratory of Functional Neurosciences (O.G., H.Y., J.S.C., C.L., A.A., C.L., M.R., M.B.) (EA 4559), Department of Biostatistics (M.D.), and Department of Rehabilitation (S.T.-P.), Jules Verne University of Picardie, Amiens; Department of Neurology (H.T., F.B.), Val-de-Grâce Hospital, Paris; Department of Neurology (C.N.-C. C.B.), La Rochelle Hospital; Department of Neurology (J.V., F.V.-G.), Saint-Étienne University Hospital; and Department of Neurology (J.-L.M.), Saint Anne Hospital, Paris, France
| | | |
Collapse
|
|
53
|
Rodríguez-Castro E, López-Dequit I, Santamaría-Cadavid M, Arias-Rivas S, Rodríguez-Yáñez M, Pumar JM, Hervella P, López-Arias E, da Silva-Candal A, Estany A, Piñeiro-Lamas M, Sobrino T, Campos F, Portela M, Vázquez-Lima M, Castillo J, Iglesias-Rey R. Trends in stroke outcomes in the last ten years in a European tertiary hospital. BMC Neurol 2018; 18:164. [PMID: 30285659 PMCID: PMC6171303 DOI: 10.1186/s12883-018-1164-7] [Citation(s) in RCA: 31] [Impact Index Per Article: 5.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/24/2018] [Accepted: 09/24/2018] [Indexed: 12/24/2022] Open
Abstract
Background Studying the impact of demographic changes and progress in the management of stroke patients is necessary in order to organize care structures for the coming years. Consequently, we analyzed the prognostic trends of patients admitted to the Stroke Unit of a tertiary hospital in the last ten years. Methods The University Clinical Hospital of Santiago de Compostela is the referral hospital for stroke in a catchment area that accounts for 16.5% of the population of Galicia. Data from patients admitted to the Stroke Unit were registered prospectively. A multinomial logistic regression was performed to determine the influence of new trends in demographic factors and in the management of patients with acute stroke. For the expected trend of progression, a 2008–2011 and 2012–2017 time series model was made by selecting the most appropriate model. Results In the last 10 years, the age of stroke onset has only increased in women (from 74.4 ± 2.2 years in 2008 to 78.8 ± 2.1 years in 2017; p = 0.037), and the same happens with the severity of neurological symptoms (ischemic stroke (IS), p < 0.0001; from 14 [10, 19] in 2008 to 19 [15, 26] in 2017), with a higher percentage of cardioembolic strokes (40.7% vs. 32.2% of cardioembolic strokes in women vs. men, p < 0.0001). In a multiple linear regression model, hospital improvement was mainly associated with the use of reperfusion treatment (B 53.11, CI 95% 49.87, 56.36, p < 0.0001). A differentiated multinomial logistic regression analysis conducted for the whole sample with ischemic strokes in the two time periods (2008–2011 and 2012–2017) showed no differences in the influence of factors associated with higher morbidity and mortality. The modeling of time series showed a distinct falling trend in mortality, with a slight increase in good outcome as well as morbidity in both ischemic and hemorrhagic stroke. Conclusions Our results showed that mortality decreased in the entire sample; however, although outcome at discharge improved in ischemic stroke, severe disability also increased in these patients. Importantly, this tendency towards increased morbidity seems to be confirmed for the coming years.
Collapse
Affiliation(s)
- Emilio Rodríguez-Castro
- Clinical Neurosciences Research Laboratory, Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain.,Stroke Unit, Department of Neurology, Hospital Clínico Universitario, Santiago de Compostela, Spain
| | - Iria López-Dequit
- Clinical Neurosciences Research Laboratory, Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain.,Stroke Unit, Department of Neurology, Hospital Clínico Universitario, Santiago de Compostela, Spain
| | - María Santamaría-Cadavid
- Clinical Neurosciences Research Laboratory, Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain.,Stroke Unit, Department of Neurology, Hospital Clínico Universitario, Santiago de Compostela, Spain
| | - Susana Arias-Rivas
- Clinical Neurosciences Research Laboratory, Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain.,Stroke Unit, Department of Neurology, Hospital Clínico Universitario, Santiago de Compostela, Spain
| | - Manuel Rodríguez-Yáñez
- Clinical Neurosciences Research Laboratory, Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain.,Stroke Unit, Department of Neurology, Hospital Clínico Universitario, Santiago de Compostela, Spain
| | - José Manuel Pumar
- Clinical Neurosciences Research Laboratory, Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain.,Department of Neuroradiology, Hospital Clínico Universitario, Santiago de Compostela, Spain
| | - Pablo Hervella
- Clinical Neurosciences Research Laboratory, Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain
| | - Esteban López-Arias
- Clinical Neurosciences Research Laboratory, Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain
| | - Andrés da Silva-Candal
- Clinical Neurosciences Research Laboratory, Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain
| | - Ana Estany
- Unit of Methodology of the Research, Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain
| | - María Piñeiro-Lamas
- Consortium for Biomedical Research in Epidemiology and Public Health, Instituto de Salud Carlos III, Madrid. Health Research Institute of Santiago de Compostela, Santiago de Compostela, Spain
| | - Tomás Sobrino
- Clinical Neurosciences Research Laboratory, Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain
| | - Francisco Campos
- Clinical Neurosciences Research Laboratory, Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain
| | - Manuel Portela
- Clinical Neurosciences Research Laboratory, Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain.,Health Area Management of Santiago de Compostela, Servicio Galego de Saúde, Santiago de Compostela, Spain
| | - Manuel Vázquez-Lima
- Emergency Department, Hospital do Salnés, Pontevedra, Vilagarcía de Arousa, Spain
| | - José Castillo
- Clinical Neurosciences Research Laboratory, Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain. .,Clinical Neuroscience Research Laboratory (Hospital Clínico Universitario), Rúa Travesa da Choupana, s/n, 15706, Santiago de Compostela, Spain.
| | - Ramón Iglesias-Rey
- Clinical Neurosciences Research Laboratory, Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain. .,Clinical Neuroscience Research Laboratory (Hospital Clínico Universitario), Rúa Travesa da Choupana, s/n, 15706, Santiago de Compostela, Spain.
| |
Collapse
|